S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911 · see citing works

The mGluR theory of fragile X mental retardation

Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · see citing works

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,139 · see citing works

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome

Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · see citing works

Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression

Mulkey, R. M., Endo, S., Shenolikar, S., & Malenka, R. C. (1994) · Nature · doi:10.1038/369486a0 · Cited by 1,083 · see citing works

Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice

Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J.-D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., et al. (2007) · Nature · doi:10.1038/nature06104 · Cited by 852 · see citing works

S6K1 −/− / S6K2 −/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway

Pende, M., Um, S. H., Mieulet, V., Sticker, M., Goss, V. L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S. C., & Thomas, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3112-3124.2004 · Cited by 743 · see citing works

Control of p70 S6 kinase by kinase activity of FRAP in vivo

Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705 · see citing works

Ribosomal S6 Kinase Signaling and the Control of Translation

Dufner, A., & Thomas, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4683 · Cited by 676 · see citing works

Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation

Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644 · see citing works

Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase

Shima, H., Pende, M., Chen, Y., Fumagalli, S., THOMAS, G. V., & Kozma, S. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6649 · Cited by 636 · see citing works

Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression

Hou, L., & Klann, E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0995-04.2004 · Cited by 527 · see citing works

Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein.

Peterson, R., Desai, B. N., Hardwick, J. S., & Schreiber, S. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.8.4438 · Cited by 496 · see citing works

Regulation of NMDA Receptors by an Associated Phosphatase-Kinase Signaling Complex

Westphal, R. S., Tavalin, S. J., Lin, J., Alto, N. M., Fraser, I. D. C., Langeberg, L. K., Sheng, M., & Scott, J. D. (1999) · Science · doi:10.1126/science.285.5424.93 · Cited by 495 · see citing works

A Decade of Molecular Studies of Fragile X Syndrome

O'Donnell, W. T., & Warren, S. T. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142909 · Cited by 481 · see citing works

Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

Raught, B., Peiretti, F., Gingras, A., Livingstone, M., Shahbazian, D., Mayeur, G. L., Polakiewicz, R. D., Sonenberg, N., & Hershey, J. W. B. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600193 · Cited by 473 · see citing works

Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice

Pende, M., Kozma, S. C., Jaquet, M., Oorschot, V. M. J., Burcelin, R., MARCHAND‐BRUSTEL, Y. L., Klumperman, J., Thorens, B., & Thomas, G. W. (2000) · Nature · doi:10.1038/35050135 · Cited by 452 · see citing works

The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E., & Thomas, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00212.x · Cited by 443 · see citing works

Metabotropic Glutamate Receptor Activation Regulates Fragile X Mental Retardation Protein and <i>Fmr1</i> mRNA Localization Differentially in Dendrites and at Synapses

Antar, L. N., Afroz, R., Dictenberg, J. B., Carroll, R. C., & Bassell, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-04.2004 · Cited by 360 · see citing works

Altered anxiety‐related and social behaviors in the <i>Fmr1</i> knockout mouse model of fragile X syndrome

Spencer, C. M., Alekseyenko, O., Serysheva, E., Yuva‐Paylor, L. A., & Paylor, R. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00123.x · Cited by 349 · see citing works

Phosphorylation influences the translation state of FMRP-associated polyribosomes

Ceman, S., O'Donnell, W. T., Reed, M., Patton, S., Pohl, J., & Warren, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg350 · Cited by 327 · see citing works

Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1

Vadlamudi, R. K., Feng, L., Adam, L., Nguyen, D. N., Ohta, Y., Stossel, T. P., & Kumar, R. (2002) · Nature Cell Biology · doi:10.1038/ncb838 · Cited by 321 · see citing works

Metabotropic Receptor-Dependent Long-Term Depression Persists in the Absence of Protein Synthesis in the Mouse Model of Fragile X Syndrome

Nosyreva, E. D., & Huber, K. M. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01316.2005 · Cited by 292 · see citing works

Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors

Nakamoto, M., Nalavadi, V., Epstein, M. P., Narayanan, U., Bassell, G. J., & Warren, S. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707484104 · Cited by 245 · see citing works

FMRP Phosphorylation Reveals an Immediate-Early Signaling Pathway Triggered by Group I mGluR and Mediated by PP2A

Narayanan, U., Nalavadi, V., Nakamoto, M., Pallas, D. C., Ceman, S., Bassell, G. J., & Warren, S. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2969-07.2007 · Cited by 228 · see citing works

Identification of Kinase-Phosphatase Signaling Modules Composed of p70 S6 Kinase-Protein Phosphatase 2A (PP2A) and p21-activated Kinase-PP2A

Westphal, R. S., Coffee, R. L., Marotta, A., Pelech, S., & Wadzinski, B. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.687 · Cited by 202 · see citing works

Post-translational protein modification as the substrate for long-lasting memory

Routtenberg, A., & Rekart, J. L. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.11.006 · Cited by 188 · see citing works

Regulation of neuronal PKA signaling through AKAP targeting dynamics

Dell’Acqua, M. L., Smith, K. E., Gorski, J. A., Horne, E. A., Gibson, E. S., & Gomez, L. L. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.01.010 · Cited by 173 · see citing works

Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver.

Flotow, H., & Thomas, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50696-2 · Cited by 158 · see citing works

Molecular Cloning and Characterization of a Novel p70 S6 Kinase, p70 S6 Kinase β Containing a Proline-rich Region

Gout, I. T., Minami, T., Hara, K., Tsujishita, Y., Filonenko, V. V., Waterfield, M. D., & Yonezawa, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30061 · Cited by 148 · see citing works

cAMP-Dependent Protein Kinase Postsynaptic Localization Regulated by NMDA Receptor Activation through Translocation of an A-Kinase Anchoring Protein Scaffold Protein

Smith, K. E., Gibson, E. S., & Dell’Acqua, M. L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3092-05.2006 · Cited by 141 · see citing works

Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticityPreprint

Antion, M. D., Merhav, M., Hoeffer, C. A., Reis, G. F., Kozma, S. C., Thomas, G., Schuman, E. M., Rosenblum, K., & Klann, E. (2008) · Learning & Memory · doi:10.1101/lm.661908 · Cited by 138 · see citing works

Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and Akt

Kanegan, M. J. V., Adams, D. G., Wadzinski, B. E., & Strack, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506986200 · Cited by 132 · see citing works

Phosphorylated tau and the neurodegenerative foldopathies

Kosik, K. S., & Shimura, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.011 · Cited by 123 · see citing works

Epidermal growth factor-mediated activation of an S6 kinase in Swiss mouse 3T3 cells.

Novak‐Hofer, I., & Thomas, G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39249-9 · Cited by 120 · see citing works

Regulation of Global and Specific mRNA Translation by Amino Acids

Kimball, S. R. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.883 · Cited by 116 · see citing works

The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites

Ferrari, S. M., Pearson, R. B., Siegmann, M., Kozma, S. C., & Thomas, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85389-9 · Cited by 113 · see citing works

Differential mRNA expression and protein localization of the SAP90/PSD‐95–associated proteins (SAPAPs) in the nervous system of the mouse

Welch, J. M., Wang, D., & Feng, G. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20060 · Cited by 113 · see citing works

Casein Kinase II Phosphorylates the Fragile X Mental Retardation Protein and Modulates Its Biological Properties

Siomi, M. C., Higashijima, K., Ishizuka, A., & Siomi, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8438-8447.2002 · Cited by 85 · see citing works

Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes

Page, G., Khidir, F. A., Pain, S., Barrier, L., Fauconneau, B., Guillard, O., Piriou, A., & Hugon, J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.01.020 · Cited by 82 · see citing works

Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression

Daw, M. I., Bortolotto, Z. A., Saulle, E., Zaman, S. H., Collingridge, G. L., & Isaac, J. T. R. (2002) · Nature Neuroscience · doi:10.1038/nn903 · Cited by 59 · see citing works

Characterization of a Conserved C-terminal Motif (RSPRR) in Ribosomal Protein S6 Kinase 1 Required for Its Mammalian Target of Rapamycin-dependent Regulation

Schalm, S. S., Tee, A. R., & Blenis, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413995200 · Cited by 57 · see citing works

Distinct spatiotemporal expression of SAPAP transcripts in the developing rat brain: a novel dendritically localized mRNA

Kindler, S., Rehbein, M., Classen, B., Richter, D., & Böckers, T. M. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.03.014 · Cited by 56 · see citing works

Cloning and Characterization of p70S6KβDefines a Novel Family of p70 S6 Kinases

Saitoh, M., ten Dijke, P., Miyazono, K., & Ichijo, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9784 · Cited by 51 · see citing works

Permeability characteristics of erythrocyte membrane to okadaic acid and calyculin A

Namboodiripad, A. N., & Jennings, M. L. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.2.c449 · Cited by 43 · see citing works

Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1

Phin, S., Kupferwasser, D., Joseph, L. A. M., & Lee-Fruman, K. K. (2003) · Biochemical Journal · doi:10.1042/bj20021794 · Cited by 26 · see citing works

mTOR signaling: At the crossroads of plasticity, memory and disease

Hoeffer, C. A., & Klann, E. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2009.11.003 · Cited by 1,128 · see citing works

Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function

Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051 · see citing works

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Magnuson, B., Ekim, B., & Fingar, D. C. (2012) · Biochemical Journal · doi:10.1042/bj20110892 · Cited by 1,015 · see citing works

Translational control of long-lasting synaptic plasticity and memory

Costa-Mattioli, M., Sossin, W. S., Klann, E., & Sonenberg, N. (2009) · Neuron · doi:10.1016/j.neuron.2008.10.055 · Cited by 944 · see citing works

Mutations causing syndromic autism define an axis of synaptic pathophysiology

Auerbach, B. D., Osterweil, E. K., & Bear, M. F. (2011) · Nature · doi:10.1038/nature10658 · Cited by 592 · see citing works

Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective

Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528 · see citing works

Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair

Jung, H., Yoon, B. C., & Holt, C. E. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3210 · Cited by 487 · see citing works

Reversible Inhibition of PSD-95 mRNA Translation by miR-125a, FMRP Phosphorylation, and mGluR Signaling

Muddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., & Bassell, G. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.006 · Cited by 364 · see citing works

Translational control of localized mRNAs: restricting protein synthesis in space and time

Besse, F., & Ephrussi, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2548 · Cited by 373 · see citing works

The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)

Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370 · see citing works

Making synaptic plasticity and memory last: mechanisms of translational regulationPreprint

Richter, J. D., & Klann, E. (2009) · Genes & Development · doi:10.1101/gad.1735809 · Cited by 345 · see citing works

Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation

Tsang, B., Arsenault, J., Vernon, R. M., Lin, H., Sonenberg, N., Wang, L., Bah, A., & Forman-Kay, J. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814385116 · Cited by 328 · see citing works

Functions and regulation of the 70 kDa ribosomal S6 kinases

Fenton, T. R., & Gout, I. T. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.09.018 · Cited by 338 · see citing works

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome

Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.221 · Cited by 336 · see citing works

Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics

Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321 · see citing works

Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice

Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., Murphy, J. P., Pierre, P., & Klann, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.022 · Cited by 316 · see citing works

Local RNA Translation at the Synapse and in Disease: Figure 1.

Liu‐Yesucevitz, L., Bassell, G. J., Gitler, A. D., Hart, A. C., Klann, E., Richter, J. D., Warren, S. T., & Wolozin, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4105-11.2011 · Cited by 289 · see citing works

mTOR: A pathogenic signaling pathway in developmental brain malformations

Crino, P. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.008 · Cited by 266 · see citing works

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome

Gross, C., Nakamoto, M., Yao, X., Chan, C.-B., Yim, S. Y., Ye, K., Warren, S. T., & Bassell, G. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0402-10.2010 · Cited by 241 · see citing works

The S6K protein family in health and disease

Tavares, M. R., Pavan, I. C. B., do Amaral, C. L., Meneguello, L., Luchessi, A. D., & Simabuco, F. M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.001 · Cited by 237 · see citing works

Abnormal mTOR Activation in Autism

Winden, K. D., Ebrahimi‐Fakhari, D., & Şahin, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061747 · Cited by 222 · see citing works

The State of Synapses in Fragile X Syndrome

Pfeiffer, B. E., & Huber, K. M. (2009) · The Neuroscientist · doi:10.1177/1073858409333075 · Cited by 214 · see citing works

Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function

Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., & Sabatini, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1617-11.2011 · Cited by 204 · see citing works

The Unstable Repeats—Three Evolving Faces of Neurological Disease

Nelson, D. L., Orr, H. T., & Warren, S. T. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.022 · Cited by 200 · see citing works

CGG repeat in the FMR1 gene: size matters

Willemsen, R., Levenga, J., & Oostra, B. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01723.x · Cited by 184 · see citing works

RNA transport and local translation in neurodevelopmental and neurodegenerative disease

Fernandopulle, M. S., Lippincott-Schwartz, J., & Ward, M. E. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00785-2 · Cited by 183 · see citing works

Behavioral phenotypes of genetic mouse models of autism

Kazdoba, T. M., Leach, P. T., & Crawley, J. N. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12256 · Cited by 179 · see citing works

What Can We Learn about Autism from Studying Fragile X Syndrome?

Budimirovic, D. B., & Kaufmann, W. E. (2011) · Developmental Neuroscience · doi:10.1159/000330213 · Cited by 176 · see citing works

Protein translation in synaptic plasticity: mGluR-LTD, Fragile X

Waung, M. W., & Huber, K. M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.03.011 · Cited by 174 · see citing works

FMR1: A gene with three faces

Oostra, B. A., & Willemsen, R. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.02.007 · Cited by 161 · see citing works

Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins

Lugo, J. N., Smith, G. D., Arbuckle, E. P., White, J., Holley, A. J., Floruta, C. M., Ahmed, N., Gomez, M. C., & Okonkwo, O. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00027 · Cited by 159 · see citing works

The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration

Liu, Y., Miao, L., Liang, F., Huang, H., Teng, X., Li, S., Nuriddinov, J., Selzer, M. E., & Hu, Y. (2014) · Nature Communications · doi:10.1038/ncomms6416 · Cited by 158 · see citing works

Fragile X Mental Retardation Protein Regulates the Levels of Scaffold Proteins and Glutamate Receptors in Postsynaptic Densities

Schütt, J., Falley, K., Richter, D., Kreienkamp, H., & Kindler, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042663 · Cited by 155 · see citing works

Evidence for a Fragile X Mental Retardation Protein-Mediated Translational Switch in Metabotropic Glutamate Receptor-Triggered Arc Translation and Long-Term Depression

Niere, F., Wilkerson, J. R., & Huber, K. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-11.2012 · Cited by 153 · see citing works

Bidirectional Regulation of Dendritic Voltage-Gated Potassium Channels by the Fragile X Mental Retardation Protein

Lee, H. Y., Ge, W., Huang, W. C., He, Y., Wang, G. X., Rowson-Baldwin, A., Smith, S. J., Jan, Y. N., & Jan, L. Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.033 · Cited by 149 · see citing works

Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors

Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_4 · Cited by 156 · see citing works

Mammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders

Chong, Z. Z., Shang, Y., Zhang, L., Wang, S., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14787 · Cited by 149 · see citing works

Fragile X syndrome: An overview and update of the FMR1 gene

Milà, M., Álvarez‐Mora, M. I., Madrigal, I., & Rodríguez‐Revenga, L. (2017) · Clinical Genetics · doi:10.1111/cge.13075 · Cited by 136 · see citing works

A recollection of mTOR signaling in learning and memoryPreprint

Graber, T. E., McCamphill, P. K., & Sossin, W. S. (2013) · Learning & Memory · doi:10.1101/lm.027664.112 · Cited by 135 · see citing works

Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants

Dwyer, J. M., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.011 · Cited by 134 · see citing works

Targeting PI3K-AKT/mTOR signaling in the prevention of autism

Sharma, A., & Mehan, S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105067 · Cited by 131 · see citing works

Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability

De Rubeis, S., & Bagni, C. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.09.013 · Cited by 126 · see citing works

Chapter 3 Ribosomal Protein S6 Kinase

Meyuhas, O., & Dreazen, A. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90003-5 · Cited by 125 · see citing works

Mechanism-based approaches to treating fragile X

Dölen, G., Carpenter, R. L., Ocain, T. D., & Bear, M. F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.008 · Cited by 124 · see citing works

Phosphorylation of Zipcode Binding Protein 1 Is Required for Brain-Derived Neurotrophic Factor Signaling of Local -Actin Synthesis and Growth Cone Turning

Sasaki, Y., Welshhans, K., Wen, Z., Yao, J., Xu, M. F., Goshima, Y., Zheng, J. Q., & Bassell, G. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0499-10.2010 · Cited by 124 · see citing works

Of Men and Mice: Modeling the Fragile X Syndrome

Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 118 · see citing works

Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin

Sundberg, M., Tochitsky, I., Buchholz, D. E., Winden, K. D., Kujala, V. J., Kapur, K., Cataltepe, D., Turner, D., Han, M., Woolf, C. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0018-4 · Cited by 120 · see citing works

The FMR1 gene and fragile X‐associated tremor/ataxia syndrome

Brouwer, J. R., Willemsen, R., & Oostra, B. A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30910 · Cited by 113 · see citing works

Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies

Banerjee, A., Ifrim, M. F., Valdez‐Sinon, A. N., Raj, N., & Bassell, G. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.008 · Cited by 103 · see citing works

TSC1/TSC2 signaling in the CNS

Han, J. M., & Sahin, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.001 · Cited by 105 · see citing works

Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back

Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105 · see citing works

Targeted treatments for fragile X syndrome

Berry‐Kravis, E., Knox, A. T., & Hervey, C. M. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9074-7 · Cited by 103 · see citing works

Genotype and cognitive phenotype of patients with tuberous sclerosis complex

van Eeghen, A. M., Black, M. E., Pulsifer, M. B., Kwiatkowski, D. J., & Thiele, E. A. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.241 · Cited by 102 · see citing works

Deregulated mTOR-mediated translation in intellectual disability.

Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. (2012) · Progress in neurobiology · doi:10.1016/j.pneurobio.2012.01.005 · Cited by 97 · see citing works

Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice

Gantois, I., Pop, A. S., de Esch, C. E. F., Buijsen, R. A. M., Pooters, T., Gomez-Mancilla, B., Gasparini, F., Oostra, B. A., D’Hooge, R., & Willemsen, R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.059 · Cited by 100 · see citing works

Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment

Inoki, K., & Guan, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp032 · Cited by 98 · see citing works

Frontier of Epilepsy Research - mTOR signaling pathway

Cho, C. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.5.032 · Cited by 92 · see citing works

Beyond controlling cell size: functional analyses of S6K in tumorigenesis

Wu, X., Xie, W., Xie, W.-X., Wei, W.-Y., & Guo, J.-P. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05081-4 · Cited by 77 · see citing works

Potential therapeutic interventions for fragile X syndrome

Levenga, J., de Vrij, F. M. S., Oostra, B. A., & Willemsen, R. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.005 · Cited by 87 · see citing works

Sapap3 Deletion Anomalously Activates Short-Term Endocannabinoid-Mediated Synaptic Plasticity

Chen, M., Wan, Y., Ade, K., Ting, J., Feng, G., & Calakos, N. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1701-11.2011 · Cited by 82 · see citing works

RNA ‐binding proteins, neural development and the addictions

Bryant, C. D., & Yazdani, N. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12273 · Cited by 79 · see citing works

mTOR and MAPK: from localized translation control to epilepsy

Pernice, H. F., Schieweck, R., Kiebler, M. A., & Popper, B. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0308-1 · Cited by 79 · see citing works

BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1

Genheden, M., Kenney, J. W., Johnston, H. E., Manousopoulou, A., Garbis, S. D., & Proud, C. G. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2641-14.2015 · Cited by 78 · see citing works

Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation

Khayachi, A., Gwizdek, C., Poupon, G., Alcor, D., Chafaï, M., Cassé, F., Maurin, T., Prieto, M. C., Folci, A., Graeve, F. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03222-y · Cited by 77 · see citing works

Translating nociceptor sensitivity: the role of axonal protein synthesis in nociceptor physiology

Price, T. J., & Géranton, S. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06786.x · Cited by 76 · see citing works

Fragile X mental retardation protein controls ion channel expression and activity

Ferron, L. (2016) · The Journal of Physiology · doi:10.1113/jp270675 · Cited by 76 · see citing works

Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders

De Rubeis, S., & Bagni, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9087-2 · Cited by 73 · see citing works

Learning and Memory Deficits Consequent to Reduction of the Fragile X Mental Retardation Protein Result from Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling inDrosophila

Kanellopoulos, A. K., Σεμελίδου, Ο., Kotini, A. G., Anezaki, M., & Skoulakis, E. M. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1347-12.2012 · Cited by 72 · see citing works

GluN3A: An NMDA Receptor Subunit with Exquisite Properties and Functions

Kehoe, L. A., Bernardinelli, Y., & Müller, D. (2013) · Neural Plasticity · doi:10.1155/2013/145387 · Cited by 70 · see citing works

BDNF in fragile X syndrome

Castrén, M. L., & Ċastrén, E. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.018 · Cited by 68 · see citing works

Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour

Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 64 · see citing works

RNA-binding proteins and translational regulation in axons and growth cones

Hörnberg, H., & Holt, C. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00081 · Cited by 64 · see citing works

Real-Time Imaging Reveals Properties of Glutamate-Induced Arc/Arg 3.1 Translation in Neuronal Dendrites

Na, Y., Park, S., Lee, C., Kim, D.-K., Park, J. M., Sockanathan, S., Huganir, R. L., & Worley, P. F. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.017 · Cited by 62 · see citing works

Subcellular Fractionation and Localization Studies Reveal a Direct Interaction of the Fragile X Mental Retardation Protein (FMRP) with Nucleolin

Taha, M. S., Nouri, K., Milroy, L. G., Moll, J. M., Herrmann, C., Brunsveld, L., Piekorz, R. P., & Ahmadian, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091465 · Cited by 64 · see citing works

Single-molecule imaging of translational output from individual RNA granules in neurons

Tatavarty, V., Ifrim, M. F., Levin, M. K., Korza, G., Barbarese, E., Yu, J. H., & Carson, J. H. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-07-0622 · Cited by 63 · see citing works

mTOR in health and in sickness

Liko, D., & Hall, M. N. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1326-7 · Cited by 59 · see citing works

Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 58 · see citing works

Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway

Lahiri, D. K., Sokol, D. K., Erickson, C. A., Ray, B., Ho, C. Y., & Maloney, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00094 · Cited by 59 · see citing works

Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice

Iliff, A. J., Renoux, A. J., Krans, A., Usdin, K., Sutton, M. A., & Todd, P. K. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds525 · Cited by 57 · see citing works

Epigenetic regulation in memory and cognitive disorders

Rudenko, A., & Tsai, L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.034 · Cited by 56 · see citing works

Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease

Wilkerson, J. R., Albanesi, J. P., & Huber, K. M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.035 · Cited by 57 · see citing works

Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice

Levenga, J., de Vrij, F. M. S., Buijsen, R. A. M., Li, T. M. W. Y., Nieuwenhuizen, I. M., Pop, A., Oostra, B. A., & Willemsen, R. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.009 · Cited by 55 · see citing works

Regulation of RNA granules by FMRP and implications for neurological diseases

Lai, A., Valdez‐Sinon, A. N., & Bassell, G. J. (2020) · Traffic · doi:10.1111/tra.12733 · Cited by 53 · see citing works

Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent α-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization

Wang, H., Kim, S. S., & Zhuo, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116293 · Cited by 52 · see citing works

Dendritic mRNA targeting and translation.

Kindler, S., & Kreienkamp, H. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_13 · Cited by 54 · see citing works

Evolution of the TSC1/TSC2-TOR Signaling Pathway

Serfontein, J., Nisbet, R. E. R., Howe, C. J., & de Vries, P. J. (2010) · Science Signaling · doi:10.1126/scisignal.2000803 · Cited by 52 · see citing works

In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation

Coffee, R. L., Williamson, A. J., Adkins, C. M., Gray, M. C., Page, T. L., & Broadie, K. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr527 · Cited by 51 · see citing works

Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse

Filippini, A., Bonini, D., Lacoux, C., Pacini, L., Zingariello, M., Sancillo, L., Bosisio, D., Salvi, V., Mingardi, J., Via, L. L., et al. (2017) · RNA Biology · doi:10.1080/15476286.2017.1338232 · Cited by 51 · see citing works

A Functional Requirement for PAK1 Binding to the KH(2) Domain of the Fragile X Protein-Related FXR1

Say, E. H. M., Tay, H.-G., Zhao, Z.-S., Baskaran, Y., Li, R., Lim, L., & Manser, E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.004 · Cited by 50 · see citing works

RNA‐binding proteins involved in RNA localization and their implications in neuronal diseases

Tolino, M., Köhrmann, M., & Kiebler, M. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08160.x · Cited by 42 · see citing works

Genome-Wide Approaches to Dissect the Roles of RNA Binding Proteins in Translational Control: Implications for Neurological Diseases

Kapeli, K., & Yeo, G. W.-M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00144 · Cited by 47 · see citing works

Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures

Bernard, P. B., Castano, A. M., O’Leary, H., Simpson, K., Browning, M. D., & Benke, T. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.013 · Cited by 48 · see citing works

FUS contributes to mTOR-dependent inhibition of translation

Sévigny, M., Bourdeau‐Julien, I., Venkatasubramani, J. P., Hui, J. B., Dutchak, P. A., & Sephton, C. F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013801 · Cited by 47 · see citing works

Dendritic protein synthesis in the normal and diseased brain

Swanger, S., & Bassell, G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.003 · Cited by 46 · see citing works

Post-Translational Modifications and RNA-Binding Proteins

Lovci, M., Bengtson, M. H., & Massirer, K. B. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-29073-7_12 · Cited by 44 · see citing works

Protein Translation in the Nucleus Accumbens Is Dysregulated during Cocaine Withdrawal and Required for Expression of Incubation of Cocaine Craving

Werner, C. T., Stefanik, M. T., Milovanovic, M., Caccamise, A. J., & Wolf, M. E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2412-17.2018 · Cited by 45 · see citing works

hnRNPs Interacting with mRNA Localization Motifs Define AxoNAl RNA Regulons

Lee, S. J., Osés-Prieto, J. A., Kawaguchi, R., Sahoo, P. K., Kar, A. N., Rozenbaum, M., Oliver, D., Chand, S., Ji, H., Shtutman, M. S., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000603 · Cited by 44 · see citing works

The mTOR Signaling Pathway Activity and Vitamin D Availability Control the Expression of Most Autism Predisposition Genes

Trifonova, E. A., Klimenko, A. I., Мустафин, З. С., Lashin, S. A., & Kochetov, A. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246332 · Cited by 43 · see citing works

Chapter 8 Translational Regulatory Mechanisms in Synaptic Plasticity and Memory Storage

Costa‐Mattioli, M., Sonenberg, N., & Richter, J. D. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90008-4 · Cited by 43 · see citing works

Autism traits in children and adolescents with Cornelia de Lange syndrome

Srivastava, S., Landy‐Schmitt, C., Clark, B. W., Kline, A. D., Specht, M. W., & Grados, M. A. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36573 · Cited by 41 · see citing works

with the Neuronal Protein Synthesis-dependent Mammalian Target of

Phosphorylates, S., & Warren, S. T. (2016)

Dysregulation of mTOR signaling in fragile X syndrome

Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557 · see citing works

Neurobiology of Disease FMRP Phosphorylation Reveals an Immediate-Early Signaling Pathway Triggered by Group I mGluR and Mediated by PP2A

Narayanan, U., Nalavadi, V., Nakamoto, M., Pallas, D. C., Ceman, S., Bassell, G. J., & Warren, S. T. (2016)

Altered synaptic plasticity in a mouse model of fragile X mental retardation

Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · see citing works

FMRP S499 Is Phosphorylated Independent of mTORC1-S6K1 Activity

Bartley, C. M., O’Keefe, R. A., & Bordey, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096956 · Cited by 38 · see citing works